Pragmatic Clinical Trial
A pragmatic trial is designed to evaluate the real-world effectiveness of an intervention in typical clinical settings with diverse, representative patients, minimal exclusion criteria, and clinically relevant outcomes. Developed by Thorpe and colleagues (2009) and formalized via the PRECIS-2 framework (2015), pragmatic trials bridge the gap between explanatory efficacy trials (conducted in controlled research settings) and implementation science, answering the question 'Does this work in actual clinical practice?' rather than 'Can this work under ideal conditions?'
Källpost
Citat kopierade ordagrant från metodens källpost. Ingen verifiering på källnivå härleds från dem.
- Thorpe, K. E., Zwarenstein, M., Oxman, A. D., Treweek, S., Furberg, C. D., Altman, D. G., ... & Tugwell, P. (2009). A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers. CMAJ, 180(10), E47–E57. · DOI 10.1503/cmaj.090523
- Loudon, K., Treweek, S., Sullivan, F., Donnan, P., Thorpe, K. E., & Zwarenstein, M. (2015). The PRECIS-2 tool: designing trials that are fit for purpose. BMJ, 350, h2147. · DOI 10.1136/bmj.h2147
- Glasziou, P., Altman, D. G., Bossuyt, P., Boutron, I., Clarke, M., Julious, S., ... & Moher, D. (2018). Reducing waste from incomplete or unusable reports of biomedical research. The Lancet, 383(9913), 267–276. · DOI 10.1016/S0140-6736(13)62228-X
Kuraterade påståenden
Påståenden lagrade i bevisloggen, var och en med sin egen bedömning.
Denna vy hittar inte på en påståendebedömning när loggen saknar en.
Relaterade metoder
Genererade från metodgrafen och visade som maskinföreslagna relationer – inga bevispåståenden härleds.